comparemela.com

Latest Breaking News On - European neuropsychopharmacology - Page 1 : comparemela.com

Study shows meth users have lower empathy and higher aggression, ecstasy users show normal empathy but more impulsive aggression

A study in the European Neuropsychopharmacology journal finds that methamphetamine users show lower empathy and higher aggression, whereas ecstasy (MDMA) users exhibit increased impulsive aggression but normal empathy levels.

Srdjan randjelovicEuropean neuropsychopharmacologyMultifaceted empathy testFace morphing taskCompetitive reaction time task

Social emotional learning | le emozioni entrano in aula con l European Trinity Day

Social emotional learning | le emozioni entrano in aula con l European Trinity Day
zazoom.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zazoom.it Daily Mail and Mail on Sunday newspapers.

United statesEuropean neuropsychopharmacology

How diet affects your mental health – Chennaionline

Diet significantly influences mental health and wellbeing, but this link is firmly established only in some areas such as the ability of a high fat and low carbohydrate diet (a ketogenic diet)

Vastra gotalands lanSuzanne dicksonProfessor at university of gothenburgEuropean neuropsychopharmacology

Running vs Antidepressants: Which Wins for Depression?

Running vs Antidepressants: Which Wins for Depression?
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaNoord hollandBrenda penninxJosinee verhoevenDr eric ruhe amsterdam university medical centresCongress is europeProfessor brenda penninx vrije universityVrije universityAmsterdam university medical centresAffective disordersEuropean neuropsychopharmacology

Medication Shortage For ADHD: Urgent FDA/DEA Action Needed, Is Cannabis An Alternative?

The shortage of stimulant-based ADHD (Attention Deficit Hyperactivity Disorder) medications like Adderall, Vyvanse and Ritalin persists, with leading drug makers unable to provide a solution. The shortage began in Fall 2022 and was exacerbated by record-high prescription rates.

United statesCalifornia institute of behavioral neuroscience psychologyTeva pharmaceutical industriesAmerican society of healthJournal of psychiatric researchAttention deficit hyperactivity disorderPharmaceutical industriesShortage and urgentAmerican societyHealth system pharmacistsEuropean neuropsychopharmacologyPsychiatric researchCalifornia instituteBehavioral neuroscience

vimarsana © 2020. All Rights Reserved.